Insiders · CBAY

Daniel Menold

Vice President, Finance at CymaBay Therapeutics, Inc. (CBAY)

Daniel Menold has filed 10 insider reports with the SEC since January 2021, as vice President and finance at CymaBay Therapeutics, Inc. (CBAY). Daniel Menold made no open-market purchases or sales in the last 12 months. In the latest filing, on January 17, 2024, Daniel Menold sold 10,000 shares of CymaBay Therapeutics, Inc. (CBAY) for $236K at an average of $23.58.

Filings
10
Companies
1
Bought on market
None
Sold on market
$967K

Companies where Daniel Menold is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
CymaBay Therapeutics, Inc. logo
CBAY
CymaBay Therapeutics, Inc.
Vice President, Finance0$967KJan 17, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Daniel Menold with

Questions about Daniel Menold

What is Daniel Menold's role at CymaBay Therapeutics, Inc.?
Daniel Menold reports to the SEC as vice President and finance at CymaBay Therapeutics, Inc. (CBAY), according to the latest filing on January 17, 2024.
Has Daniel Menold bought or sold stock recently?
The most recent open-market sale was on January 16, 2024: sold 10,000 shares of CymaBay Therapeutics, Inc. (CBAY) for $236K at an average of $23.58.
How do I get alerts when Daniel Menold files?
Follow Daniel Menold on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Daniel Menold (SEC CIK 0001705745). Totals count each trade once, skipping amendments whose original is on file, from Jan 28, 2021 on. View on SEC EDGAR · Get this as JSON